ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) - FEASIBILITY AND EFFICACY OF PROLONGED IMMUNOCHEMOTHERAPY WITH RITUXIMAB (R), ARAC AND FLUDARABINE ADDED TO CHOP AND FOLLOWED BY RITUXIMAB MAINTENACE. A PROSPECTIVE STUDY BY THE FINNISH LYMPHOMA GROUP
ANNALS OF ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要